Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics Inc | RCV000993045 | SCV001145747 | likely pathogenic | not provided | 2022-09-26 | criteria provided, single submitter | clinical testing | This variant appears to segregate with spastic paraplegia in at least one family. Functional studies showed that mutant proteins have reduced microtubule affinity but still possess the regulatory mechanisms (PMID: 18203753). This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). |
Ce |
RCV000993045 | SCV001250238 | pathogenic | not provided | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Paris Brain Institute, |
RCV000007209 | SCV001451233 | pathogenic | Hereditary spastic paraplegia 10 | criteria provided, single submitter | clinical testing | ||
Invitae | RCV001387529 | SCV001588190 | pathogenic | Spastic paraplegia | 2022-12-29 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg280 amino acid residue in KIF5A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 18853458, 25008398, 28832565, 29892902). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects KIF5A function (PMID: 18203753). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 6807). This missense change has been observed in individuals with KIF5A-related conditions (PMID: 15452312, 25008398, 31211173; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 280 of the KIF5A protein (p.Arg280Cys). |
Institute of Medical Genetics and Applied Genomics, |
RCV000993045 | SCV001762183 | pathogenic | not provided | 2021-06-17 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847593 | SCV002105383 | pathogenic | Hereditary spastic paraplegia | 2016-12-12 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000007209 | SCV000027405 | pathogenic | Hereditary spastic paraplegia 10 | 2014-08-12 | no assertion criteria provided | literature only |